Followup Results of a Combination of Calcitonin Gene-Related Peptide and Prostaglandin E1 in the Treatment of Erectile Dysfunction

Prognostic Factors for the Postoperative Outcome of Penile Venous Surgery for Venogenic Erectile Dysfunction

“…They also are informed about the implication of this finding with either the alternative of further diagnostics, for example cavernosometry and cavernosography, or other therapeutic strategies, such as vacuum devices, a penile prosthesis or a trial with intracavernous injection of a combination of calcitonin gene-related peptide plus prostaglandin El. 21 In patients who choose further diagnostic procedures, cavernosometry and cavernosography are done as described previously. 20 The maintenance flow is measured after cavernous smooth muscle relaxation is induced by intracavernous injection of 30 mg. papaverine plus 1 mg. phentolamine, with a flow rate exceeding 14 ml.…”

Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction

“…55 In another study performed by Schwarzer et al, 30% of patients who failed 40 mg PGE 1 or 80 mg papaverine or the combination of 60 mg papaverine plus 2 mg phentolamine obtained rigid erections following treatment with 5 mg CGRP plus 20 mg PGE 1 . 56 Since these reports which appeared nearly a decade ago, no further reports on the validity and safety of the CGRPaPGE 1 combination have been published.…”

The influence of medication on erectile function

“…injection therapy, for example the use of the NO donors linsidomin and of calcitonin gene related peptide. 55,56 The data from research of oral medication acting on these systems becomes available now. 53,54,57 Prescription drugs…”